Glucon
Development stage company developing glucose monitoring devices for the diabetes market
At a glance
- Status
- Closed
- Founded
- 2000
- Headquarters
- Boulder, United States
- Open positions
- None listed
- Dealroom signal
- 0.0/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Personal Health, Diabetes, Biotechnology, Wearable, Hard Tech, DT and LS
- Technology
- Hardware, Deep Tech, Computer Vision, Connected Device
- Business model
- Manufacturing
- Client focus
- b2b
- Links
- Website
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
Growth signals
Latest recorded traffic for Glucon is 280 monthly website visits, up 250% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Giza Venture Capital
Series B and later7 investors entered at this stage
3i Group- SPSequel Venture Partners
Aurum Ventures- MKMKI
- QCQuest Capital
Covera Ventures- AVAscend Technology Ventures
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Glucon on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Glucon’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







